Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9356724 | 0.77 | MEN1 (0.44) | POLBEPHX2CYP2C19 | |
| SCHEMBL2829186 | 0.76 | — | — | |
| SCHEMBL15552174 | 0.75 | ALDH1A1 (0.48) | POLBEPHX2CYP2C19 | |
| SCHEMBL11908564 | 0.75 | ALDH1A1 (0.48) | POLBEPHX2CYP2C19 | |
| SCHEMBL16277091 | 0.74 | FAAH (0.45) | — | |
| SCHEMBL27410603 | 0.73 | CYP2C19 (0.43) | POLBEPHX2CYP2C19 | |
| SCHEMBL22539971 | 0.72 | FAAH (0.58) | EPHX2 | |
| SCHEMBL11363178 | 0.72 | POLB (0.37) | POLBEPHX2CYP2C19 | |
| SCHEMBL11354349 | 0.71 | RAB9A (0.40) | POLB | |
| SCHEMBL16276160 | 0.71 | FAAH (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4284445-A1 | MULTIMERIC CHELATOR COMPOUNDS FOR USE IN TARGETED RADIOTHERAPY | Bayer Aktiengesellschaft (DE) | 2023-12-06 | — | — | EP | disclosed |
| WO-2022162210-A1 | MULTIMERIC CHELATOR COMPOUNDS FOR USE IN TARGETED RADIOTHERAPY | BAYER AKTIENGESELLSCHAFT (DE) | 2022-08-04 | — | — | WO | disclosed |